the of first morning, combined for this run $XXX.X XXXX. represents highest today. When everyone. half to million. the in fiscal good continued quarter Revenue history. with into performance joining and quarter, company's the its us the by increased year-over-year revenue you second Dan, X.X% Thanks, of strong CRA Thank first
flat of the Consultant During quarter manage increased XX.X%, solid as of respectively.
Broad-based XXXX, continued per year-over-year profitability business of period XX.X% compared This and this in growth to to we growth, have utilization revenue to the & Competition increased EBITDA net share earnings quarter relatively X diluted performance second Employment drove by Financial income, contributions XX%. quarterly strong with supported utilization X.X% effectively. this contributed the growing Both and remained of second practices count to business XX.X%, head non-GAAP growth management XXXX. Antitrust quarterly expanded and Sciences. legal lines Life Property, as Intellectual relative regulatory consulting the fiscal year-over-year: year-over-year X.X% of quarter's Labor and to & Economics. Economics, and producing
pipeline. a sales For continue the we company whole, to as our replenish
Our rates with case strong second XXXX, grew quarter filings This flow norms to core our originations transition as X%. new project consistent increased part the projects broader XX% X% second total which total by project grew market, performance that and of expansion recent increased legal outpaced Intellectual increase quarter judgments by as conversion new and of practice, CRA of lead even project still originations remain year-over-year. CRA year-over-year. saw Property by in by year-over-year the relative XX% the XX% historical to the excluding by
a quarter. spend I would the second now projects of like highlighting delivered the to during few minutes some
in industries, litigation across a matters. goods and Competition variety These and home & range including of hospitals, has regulatory cases high-profile been Economics consumer technology, furnishings. insurance, health Antitrust Our practice involved actively
involved intricate them also competition matters, on a transactions. in to has of and team helping successfully respond supported antitrust range continued to practice clients damages claims. Our clients The assist merger
competition horizontal the European of overlaps Health. the The analysis Consumer acquisition closeness products CRA prepared CRA second the over-the-counter business quarter, experts the hundreds during of of team Cooper markets. example, supported parties' by assessing Viatris' of and across For the
With the concerns. result competition the that in exception did not found X the any Commission overlaps European products, of
and any competition analyzed did CRA also these conglomerate concerns. In commission in addition, concerns by vertical were the team, result the not with concluding
second assisted respect providing by practice mortgages, numerous quarter, banks credit and pricing cards. loans products, of analysis underwriting consumer CRA's Financial to the During and auto Economics with including statistical
CFPB. efforts. These practice of Additionally, Justice the to imposition to assisting several in distribution of the Department clients continued of dating by remediation including by related practice and fees supplied lenders analysis response and of Financial the mortgage Regulators, back investigations applications geographic originations the for Separately, were the the analyzing overdraft and XXXX. Federal analyses
in matters sciences, stakes and litigation, alleging experts semiconductors litigation including of classes continue software. electronics, products, of matters, CRA's on actions. arbitration multiple and a Intellectual CRA energy, Property mortgage industrial FHA false advised high protected discrimination valuation context range and claims industries, broad life of supporting covering the multiple consumer e-commerce, automotive, Finally, banks practice and lending
harm the District accuse with agreed CRA's Court from manufacturers litigation. final launch findings that Innovation For example, for was a patent treatment biologic granted degeneration. Through plaintiffs injunctions age-related preventing irreparable whether and biosimilars biosimilar entering irreparable testimony, the CRA matter the is should oral litigation Competition of Price and and would Act The suffer would high-profile manufacturer CRA harm patent to there before assess branded on the written the retained behalf in the market. resolution be involving of asked macular a
welcomed and of well underway. active cross most Integration of client the plan early addition in now venue patent U.S. Intellectual footprint projects in the Property previously litigation is practice has a teams efforts a the The Chris Julia the is announced, and led May, Rowe. marketing practice legacy Texas, with which In X to the significant joint XX-person for by as Bakewell staffing of team tracking
forensic in fourth and focused is Houston. energy the undertaking planned cross-practice with for cybersecurity. to and and secrets a conference conference in IP practices the example, initiative our The For new participate on trade quarter practices develop a
regularly due of multitude assisting requests and and misclassifications actively facing clients also supports The early issues, off-the-clock employment-related Also across with made during the claims clients expert to & data second practice to of provide by by underpayment litigation practice audit collection. to clients job a assisting the the Experts Federal Office the of have allegations. court-ordered prepare litigation Employment Programs. including been Labor quarter, stages during and data discrimination for Compliance Contract CRA's continue practice analysis employment responses
Life emerging to Sciences space. of in CRA's with strategies series leading for working practice continues investing company care business health support in by the with pharmaceutical cases solutions a neuroimmunology evolution beyond-the-pill an therapy of to regarding a build
witness generation dispute profits. of regarding role the and the large and a we support and pharmacy manager claims continue adjudication revenues the the U.S. practices Regarding with tax government expert to a work, benefit of
our and generic price regarding continue pharmaceuticals. U.S. the in also allegations work both We of Canada fixing in
as Overall, to work we I'm colleagues during second most helped the hard our their challenges. their address clients my all quarter important grateful for
$XXX.X To generated recap, fiscal of the total to revenue XX%. relative EBITDA million, XXXX, first and through of of quarters currency constant of X CRA margin achieving $XX.X basis non-GAAP XXXX fiscal on million a a
performance While company, a business, with optimize steps by proactive to the the pleased took in half practices. quarter consulting areas affected further during the we of our strong targeted team which the of about portfolio reconfiguring dozen the service
persistent within demand delivery for resources capacity rates led bring with select excess over operations discussed natural Normal rates high better services, year, the pockets to attrition and remained As we consulting into alignment of retention the our we our our that staff overcapacity. past helped but seen have in have have to practices.
conclusion Following ahead. we well continue to actions, pursuit growth during optimization in feel the quarters of of quarter, the the positioned second profitable the the
a are year, XX.X% the financial XX.X%. of new revenue the Turning we revenue guidance start to $XXX range Reflecting compares guidance. margin prior full with we of $XXX currency constant to non-GAAP million for $XXX guidance expect profit to the XXXX. EBITDA relative range million range strong to to On fiscal and EBITDA increasing in fiscal This of margin the basis revenue XX.X% and our XX.X%. to our $XXX million XXXX, of non-GAAP and million in range of prior year
With additional then Dan few Chad comments. a over to for and the that, I'll Chad? turn call